M&T Bank’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-30,735
| Closed | -$608K | – | 1572 |
|
|
2024
Q4 | $608K | Hold |
30,735
| – | – | ﹤0.01% | 1093 |
|
|
2024
Q3 | $768K | Sell |
30,735
-5,654
| -16% | -$141K | ﹤0.01% | 996 |
|
|
2024
Q2 | $680K | Buy |
36,389
+55
| +0.2% | +$1.03K | ﹤0.01% | 999 |
|
|
2024
Q1 | $717K | Sell |
36,334
-78
| -0.2% | -$1.54K | ﹤0.01% | 998 |
|
|
2023
Q4 | $638K | Sell |
36,412
-601
| -2% | -$10.5K | ﹤0.01% | 1035 |
|
|
2023
Q3 | $643K | Sell |
37,013
-20,255
| -35% | -$352K | ﹤0.01% | 981 |
|
|
2023
Q2 | $806K | Buy |
57,268
+13,306
| +30% | +$187K | ﹤0.01% | 944 |
|
|
2023
Q1 | $474K | Buy |
43,962
+14,298
| +48% | +$154K | ﹤0.01% | 1135 |
|
|
2022
Q4 | $444K | Sell |
29,664
-8,776
| -23% | -$131K | ﹤0.01% | 1150 |
|
|
2022
Q3 | $494K | Sell |
38,440
-8,856
| -19% | -$114K | ﹤0.01% | 1085 |
|
|
2022
Q2 | $458K | Hold |
47,296
| – | – | ﹤0.01% | 1045 |
|
|
2022
Q1 | $470K | Buy |
47,296
+25,612
| +118% | +$255K | ﹤0.01% | 1020 |
|
|
2021
Q4 | $255K | Buy |
21,684
+1,183
| +6% | +$13.9K | ﹤0.01% | 1328 |
|
|
2021
Q3 | $234K | Buy |
20,501
+9,611
| +88% | +$110K | ﹤0.01% | 1364 |
|
|
2021
Q2 | $152K | Hold |
10,890
| – | – | ﹤0.01% | 1487 |
|
|
2021
Q1 | $202K | Buy |
+10,890
| New | +$202K | ﹤0.01% | 1421 |
|
|
2020
Q1 | – | Sell |
-16,299
| Closed | -$180K | – | 1569 |
|
|
2019
Q4 | $180K | Buy |
16,299
+2,808
| +21% | +$31K | ﹤0.01% | 1277 |
|
|
2019
Q3 | $115K | Buy |
13,491
+3,092
| +30% | +$26.4K | ﹤0.01% | 1488 |
|
|
2019
Q2 | $141K | Buy |
+10,399
| New | +$141K | ﹤0.01% | 1466 |
|